UNSPSC 51391742: Isoprenaline

This classification denotes a bronchodilator with the molecular formula C11H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L628TT009W, chemically known as 3,4-dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol but generally known as isoprenaline, which bears US NIH Compound Identifier 3779. European Medicines Agency schedules Isoprenaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08330MIG. The term ISOPRENALINE is an International Non-Proprietary Name.

UNSPSC 51391742 Isoprenaline is a Commodity code that state and local health authorities are using to procure emergency pharmaceutical supplies and related health-system products, though recent solicitation activity shows a mismatch between the code's nominal scope and the actual work being bought. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding, with quarterly deliveries to the county's Community Health Building and a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities and market intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit managers, group purchasing organizations, and wholesalers. The issuing bodies under this code span county health departments and state health agencies, with recent activity concentrated in county-level public health procurement and state-level pharmacy benefit program development rather than procurement of isoprenaline specifically.

Geographic activity appears concentrated in Florida and Texas based on the recent two-opportunity sample. The Seminole County solicitation (IFB, response due July 26, 2023) represents traditional public health supply procurement with fixed-fee pricing, drug-free workplace certification requirements, E-Verify compliance, and potential FEMA funding that introduces Clean Air Act and Federal Water Pollution Control Act compliance obligations. The Texas HHS RFI represents exploratory market intelligence gathering ahead of formal procurement and does not establish binding timelines, award values, or evaluation criteria. The code shows limited recent activity tagged to its nominal pharmaceutical scope, and the opportunities recorded do not align closely with isoprenaline procurement — Naloxone and drug deactivation systems represent opioid-response products, while the Texas RFI addresses pharmacy benefit program structure rather than specific drug commodities. Vendors pursuing this code should verify that posted opportunities are actually drug-supply or pharmaceutical-system buys before committing proposal resources.